Gillette India Ltd
Gillette India Limited is a public company incorporated under the provisions of the Companies Act 1956. The company is engaged in manufacturing and selling of packaged fast moving goods under its various brands in the grooming and oral care segment.
Gillette sells razors and blades, shaving gel, shaving cream and after shave through various modes like drug stores, department stores, grocery stores, mass merchandisers, membership club stores. [1]
- Market Cap ₹ 32,018 Cr.
- Current Price ₹ 9,811
- High / Low ₹ 10,699 / 5,950
- Stock P/E 70.8
- Book Value ₹ 298
- Dividend Yield 0.46 %
- ROCE 58.9 %
- ROE 42.5 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 38.9%
- Company has been maintaining a healthy dividend payout of 86.2%
Cons
- Stock is trading at 32.9 times its book value
- The company has delivered a poor sales growth of 7.18% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Multinational
Part of BSE 400 MidSmallCap Index BSE Quality Index BSE 500 Nifty Smallcap 250 Nifty Total Market
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,424 | 1,662 | 1,875 | 1,755 | 1,733 | 1,677 | 1,862 | 1,679 | 1,982 | 2,256 | 2,477 | 2,633 | 2,747 | |
1,290 | 1,589 | 1,684 | 1,448 | 1,348 | 1,290 | 1,478 | 1,319 | 1,522 | 1,773 | 1,937 | 1,999 | 2,065 | |
Operating Profit | 134 | 73 | 191 | 306 | 385 | 387 | 384 | 360 | 460 | 483 | 540 | 634 | 682 |
OPM % | 9% | 4% | 10% | 17% | 22% | 23% | 21% | 21% | 23% | 21% | 22% | 24% | 25% |
36 | 38 | 68 | 50 | 34 | 8 | 11 | 11 | 32 | 7 | 22 | 20 | 25 | |
Interest | 0 | 0 | 5 | 6 | 7 | 7 | 8 | 5 | 5 | 11 | 8 | 9 | 11 |
Depreciation | 31 | 33 | 39 | 30 | 38 | 42 | 48 | 51 | 58 | 68 | 81 | 83 | 82 |
Profit before tax | 138 | 78 | 215 | 320 | 374 | 345 | 339 | 314 | 429 | 411 | 473 | 562 | 614 |
Tax % | 37% | 34% | 26% | 33% | 32% | 34% | 25% | 27% | 28% | 30% | 25% | 27% | |
87 | 51 | 158 | 214 | 253 | 229 | 253 | 230 | 310 | 289 | 356 | 412 | 452 | |
EPS in Rs | 26.75 | 15.78 | 48.53 | 65.73 | 77.67 | 70.29 | 77.62 | 70.64 | 95.25 | 88.79 | 109.15 | 126.35 | 138.72 |
Dividend Payout % | 56% | 95% | 31% | 60% | 211% | 33% | 57% | 69% | 125% | 78% | 78% | 103% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 7% |
3 Years: | 10% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | 23% |
5 Years: | 10% |
3 Years: | 10% |
TTM: | 25% |
Stock Price CAGR | |
---|---|
10 Years: | 11% |
5 Years: | 7% |
3 Years: | 22% |
1 Year: | 54% |
Return on Equity | |
---|---|
10 Years: | 34% |
5 Years: | 36% |
3 Years: | 39% |
Last Year: | 42% |
Balance Sheet
Figures in Rs. Crores
Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
Reserves | 617 | 611 | 710 | 904 | 468 | 662 | 746 | 879 | 756 | 829 | 956 | 939 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
390 | 411 | 468 | 488 | 498 | 515 | 432 | 441 | 606 | 758 | 927 | 859 | |
Total Liabilities | 1,039 | 1,054 | 1,210 | 1,424 | 998 | 1,209 | 1,210 | 1,352 | 1,395 | 1,619 | 1,916 | 1,831 |
170 | 173 | 156 | 178 | 214 | 264 | 300 | 296 | 310 | 363 | 389 | 347 | |
CWIP | 30 | 61 | 63 | 88 | 63 | 40 | 25 | 21 | 72 | 65 | 32 | 26 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
839 | 821 | 991 | 1,158 | 721 | 904 | 886 | 1,034 | 1,013 | 1,191 | 1,494 | 1,458 | |
Total Assets | 1,039 | 1,054 | 1,210 | 1,424 | 998 | 1,209 | 1,210 | 1,352 | 1,395 | 1,619 | 1,916 | 1,831 |
Cash Flows
Figures in Rs. Crores
Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
29 | 96 | 172 | 279 | 248 | 237 | 134 | 225 | 443 | 462 | 463 | 509 | |
78 | -36 | -103 | 155 | 14 | -77 | -65 | -29 | -79 | -112 | -67 | -49 | |
-57 | -57 | -58 | -79 | -684 | -39 | -165 | -105 | -430 | -225 | -231 | -440 | |
Net Cash Flow | 51 | 3 | 12 | 356 | -422 | 121 | -95 | 91 | -66 | 125 | 164 | 20 |
Ratios
Figures in Rs. Crores
Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 24 | 20 | 23 | 23 | 27 | 38 | 36 | 41 | 36 | 43 | 47 | 38 |
Inventory Days | 131 | 104 | 87 | 104 | 103 | 105 | 104 | 136 | 152 | 130 | 127 | 131 |
Days Payable | 122 | 116 | 116 | 137 | 150 | 173 | 126 | 138 | 169 | 193 | 209 | 212 |
Cash Conversion Cycle | 33 | 9 | -6 | -10 | -19 | -30 | 15 | 40 | 19 | -20 | -35 | -43 |
Working Capital Days | 48 | 27 | 49 | -10 | -17 | -18 | 15 | 35 | 14 | -0 | -4 | -7 |
ROCE % | 22% | 12% | 35% | 39% | 54% | 60% | 48% | 38% | 51% | 51% | 52% | 59% |
Documents
Announcements
- Proceedings Of 40Th AGM Held On December 3,2024 4h
-
Change In Senior Management Personnel Of The Company
1d - Change in leadership for Personal Health Care category.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 27 Nov
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 27 Nov
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 15 Nov
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Concalls
-
Sep 2024Transcript PPT
-
Sep 2023Transcript PPT
-
May 2023TranscriptNotesPPT
Portfolio of well known Brands[1]
Gillette, Venus, Braun, Oral B